Net income of Fulgent Genetics under GAAP for 2021 was $506.239 million, up 2.4 times from $214.31 million in the previous year. Revenue increased 2.4 times to $992.584 million from $421.712 million a year earlier.
Net income of Fulgent Genetics under GAAP for 2021 was $506.239 million, up 2.4 times from $214.31 million in the previous year. Revenue increased 2.4 times to $992.584 million from $421.712 million a year earlier. 
fulgentgenetics.gcs-web.com
English (US) 